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Abstract  
Background: Uptake of screening remains crucial in the prevention of both the incidence of colorectal cancer (CRC) and its 
mortality. 
Objectives: To estimate the prevalence of CRC screening and identify chronic conditions that predict CRC screening uptake 
among US adults using the 2012 National Health Interview Survey (NHIS) data.  
Materials and Methods: A cross-sectional analysis of the 2012 NHIS data. Chronic conditions examined were hypertension, 
cancer history, arthritis, ulcer, and high cholesterol level. A total of 21,511 participants were included in the analysis. Weighted 
univariate and multiple logistic regression analyses in SAS ver. 9.2 were used to estimate the odds ratios (ORs) with 95% 
confidence intervals (CIs). 
Results: The overall prevalence of CRC screening was 19%. The prevalence of CRC screening in adults with cancer history, 
hypertension, ulcer, high cholesterol, and arthritis was significantly higher than those without the chronic conditions (26% 
vs.18%, 23% vs.16%, 25% vs.18%, 23% vs. 16%, and 23% vs. 17%, respectively). After adjusting for potential factors, 
hypertension (OR=1.18, 95%CI=1.08-1.30), ulcer (OR=1.28, 95%CI=1.10-1.48), high cholesterol (OR=1.25, 
95%CI=1.14-1.39), and arthritis (OR=1.24, 95%CI=1.12-1.37) were all positively associated with CRC screening (p<0.05). 
Females were less likely to screen for CRC than to males (OR=0.72; 95% CI=0.65-0.80). Compared to young adults (18-44 
years), screening was significantly higher in middle-aged (45-64 years) and elder adults (65+) (OR=2.60, 95%CI=2.11-3.21 and 
OR=2.67, 95%CI=2.13-3.33, respectively). African Americans were more likely to screen for CRC compared to their white 
counterparts (OR=1.61, 95% CI=1.44-1.81).   
Conclusions: We have found significant associations between chronic conditions and CRC screening uptake. We also found 
higher uptake of CRC screen in African Americans than Whites, in contrast to earlier findings.  
 
          American Journal of  
Cancer Epidemiology and Prevention 
 
 
 
 
 
Research Article  
 
American Journal of  
Cancer Epidemiology and Prevention 
http://ivyunion.org/index.php/ajcep  
Vol.2, Article ID 201400515, 11 pages 
 
 Owusu D et al. American Journal of Cancer Epidemiology and Prevention 2014, 2:32-42 
  
Ivy Union Publishing | http: //www.ivyunion.org November 29, 2014 | Volume 2 | Issue 1
  
Page 2 of 11 
Introduction 
Colorectal cancer (CRC) is the fourth leading cause of cancer mortalities globally [1]. It accounted for    
608, 000 deaths worldwide in 2008 [1]. CRC affects both sexes significantly. In the United States (US), CRC 
is the third most common cancer and the second leading cause of cancer deaths; it was estimated that 136, 830 
people would be diagnosed with CRC and about 50, 310 people would die of the disease in the US in 2014 [2]. 
The lifetime risk of CRC is about 5% for both men and women in the US [3, 4]. Five year survival rate of 
CRC is low at late diagnosis of the disease; however, CRC death can be prevented by early detection and 
treatment. Five-year survival rate has been shown to be at least 90% when the condition is detected early and 
treated before tumor has extended; survival reduces to 70% when tumor has extended and is under 13% when 
metastasis has already taken place [3, 5].  
  Deaths from CRC have been decreasing for both men and women in the US [6]. There has also been 
declining rate of CRC incidence which is attributed to a reduction in exposure to risk factors, early detection, 
and prevention by polypectomy [7]. Early detection, prevention, and early treatment are possible due to 
availability of screening programs for at risk groups in the US. Uptake of screening therefore remains crucial 
in the prevention of both the incidence of CRC and its mortality. Screening for CRC is effective, safe, and 
relatively inexpensive [8]. A significant reduction in deaths from CRC attributed to screening has been shown 
in both randomized trials and observational studies [9-12]. Different screening tools exist for CRC. Sensitivity 
and specificity for various tests have been shown to be appropriate for screening [8]. For instance, a clinical 
trial has shown that a single sigmoidoscopy screening of adults between 55 and 64 years resulted in 33% and 
43% reductions in incidence and mortality of CRC, respectively [13]. In the US, a consensus guideline for 
CRC screening has been published and screening is covered by most health plans [14]. 
  However, uptake of CRC screening is still about 50% of those eligible or for whom the test is highly 
recommended [2, 15]. Predictors of CRC screening are similar to those of other tests and they include age, 
educational level, income level, being married, and health insurance status [15, 16]. But unlike other cancer 
screening tests such as mammography, CRC screening rates remains low despite availability of effective and 
safe test tools. In contrast to the well-known gender differences in health behavior [17], men show higher 
acceptance rate for CRC screening than females [18,19]. Public health researchers have sought to find an 
answer to this deviation. Some have asserted that the observation may be explained by the fact that the 
incidence of colonic adenomas is higher in men than women [20], hence, the assumption that it is a male 
condition [21]. Others also observed that over-emphasis on similar health conditions with screening guidelines 
specific to women such as breast and cervical cancer seem to have focused women’s attention on those 
conditions to the detriment of CRC screening [22,23]. However, since physician visits have been found to 
correlate with CRC screening [21,24], it is expected that women screening for breast cancer and other diseases 
will receive information on CRC risk and the need for screening. Such awareness will dispel any 
misconception about CRC. On the other hand, if attention to other well publicized health programs hinders 
CRC screening, it raises a question regarding the effect one health concern has on other important health 
issues. Will attention to other chronic disease affect health behavior towards another important health issues? 
Studies have so far not well evaluated the association between chronic diseases and CRC screening. A study to 
find this association will not only answer an important question but will also inform policy about the need to 
tailor CRC screening to other chronic disease management. 
Methods 
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Data source 
The National Health Interview Survey (NHIS) is a multi-purpose health survey conducted by the National 
Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), and is the principal 
source of information on the health of the civilian non-institutionalized household population of the US. The 
NHIS has been conducted continuously since 1957. Public use data files are released on an annual basis. From 
each family in the NHIS, one sample adult aged 18 years or older is randomly selected, and information is 
collected with sample adult core questionnaires. The 2012 NHIS sample size is the largest sample size since 
the current sample design was implemented in 2006. Detailed methods of this survey have been published 
elsewhere [25]. 
Variables 
Subjects were considered to have had CRC screening if they responded “yes” to the question “During the past 
12 months, have you had any test done for colon cancer?” (Table 1). Colon cancer tests include blood stool 
tests, colonoscopy and sigmoidoscopy. A blood stool test is a test that may use a special kit at home to 
determine whether the stool contains blood. A sigmoidoscopy and colonoscopy involve insertion of a tube into 
the rectum to view the colon for signs of cancer or other health problems. Social factors used in this study 
were age group classified as young (18-44 years), middle aged (45-64 years), and elderly (65 years or older), 
gender, race/ethnicity (White, African American (AA), Asian and other). Other demographic characteristics 
included education (≤high school, > high school) and health insurance (yes, no). Marital status had three 
categories: married/living with partner, widowed/divorced/separated, and never married. All health condition 
variables were dichotomized to yes or no. Cancer history was defined by the question “Ever been told by a 
doctor you had cancer?” Arthritis was defined by the question “Ever been told by a doctor you had arthritis?” 
Hypertension was asked by the question “Ever been told by a doctoryou had hypertension?” High cholesterol 
was determined by the question “Ever been told by a doctor you had high cholesterol?” Ulcer was defined by 
the question “Ever been told by a doctor you had an ulcer?”  
Statistical Analysis 
The SAS PROC SURVEYFREQ procedure was used to weight and estimate population proportions in 
chronic conditions and social factors. SAS PROC SURVEYMEANS was used to estimate the overall 
prevalence of CRC screening, whereas SAS PROC SURVEYFREQ determined the prevalence in potential 
determinants. The Chi-square test was used to compare prevalence across chronic conditions. Then, SAS 
PROC SURVEYLOGISTIC was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) 
for the relationship between potential factors and CRC screening. We estimated both crude and adjusted odds 
ratios for our independent variables. Since colorectal cancer incidence increases with age, we set the young 
adults as our reference for the analysis. All the analyses were conducted with SAS statistical software, version 
9.2 (SAS Institute, Cary, NC, USA).  
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Table 1 Subjects characteristics of the 2012 National Health Interview Survey 
 
Variable 
CRC screening (weighted %) 
N=4,040 
Non-screening (Weighted %) 
N=17,471     
Gender   
  Male 2026(54%) 7516(46%) 
  Female 2014(46%) 9955(54%) 
Age group   
  18-44 years 182(5%) 2609(16%) 
  45-64 years  2194(59%) 9340(57%) 
  65 + 1664(36%) 5522(27%) 
Race   
  White 2819(79%) 13015(80%) 
  AA 800(13%) 2469(10%) 
  Asian 129(3%) 547(3%) 
  Other 292(5%) 1440(7%) 
Marital status   
  Married 2205(70%) 8916(66%) 
Widowed/Divorced/Separate 1447(24%) 6401(25%) 
  Never 385(6%) 2105(9%) 
Education   
  ≤HS 1776(42%) 8668(49%) 
  >HS 2210(58%) 8438(51%) 
Insurance   
  No 106(2%) 1597(7%) 
  Yes 3933(98%) 15857(93%) 
Cancer history   
  No 3285(82%) 15406(88%) 
  Yes 753(18%) 2054(12%) 
Hypertension   
  No 1833(48%) 9899(60%) 
  Yes 2203(52%) 7549(40%) 
Ulcer   
  No 3574(89%) 16013(92%) 
  Yes 462(11%) 1444(8%) 
High cholesterol   
  No 2078(52%) 10976(63%) 
  Yes 1953(48%) 6432(37%) 
Arthritis   
  No 2364(60%) 11822(69%) 
  Yes 1673(40%) 5629(31%) 
Abbreviations: AA=African American; HS=High school 
*Data Source: CDC/NCHS, National Health Interview Survey, 2012 
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Table 2 CRC screening prevalence in chronic disease conditions (%) 
 
 
Variable 
 
 
Total  (N) 
      
 
CRC screening  (N)      
 
Prevalence (%)    
 
95%CI    
 
P 
 
Cancer history 
     
   No 18691 3285 17.6 16.9-18.3 <0.0001 
   Yes 2807 753 26.4 24.4-28.4  
Hypertension      
   No 11732 1833 15.8 14.9-16.6 <0.0001 
   Yes 9752 2203 22.7 21.8-23.7  
Ulcer      
   No 19587 3574 18.2 17.5-18.8 <0.0001 
   Yes 1906 462 25.0 22.6-27.3  
High cholesterol      
   No 10976 2078 15.9 15.1-16.7 <0.0001 
   Yes 8385 1953 23.3 22.2-24.4  
Arthritis      
   No 14186 2364 16.5 15.8-17.3 <0.0001 
   Yes 7302 1673 23.4 22.1-24.6  
Overall  21511 4040 18.8 18.1-19.4  
P-value is based on χ2 test 
*Data Source: CDC/NCHS, National Health Interview Survey, 2012 
 
Results 
Subjects characteristics and prevalence  
A total of 21,511 respondents, comprising 9,542 (44%) males and 11,966 (56%) females were included in the 
analysis. Table 1 shows the characteristics of the study participants. In males, the percentage of CRC 
screening was higher than the non-screening group (54% vs. 46%). Prevalence of CRC screening was higher 
in older adults than young adults (36% vs. 27%). AA adults and married adults reported higher cases of CRC 
screening than Whites and never married respectively (13% vs. 10%, 70% vs. 66%, respectively). More adults 
with higher education and health insurance received CRC screening than low education and uninsured (58% 
vs. 51%, 98% vs. 93%, respectively).  
 
Table 2 shows the prevalence of CRC screening in chronic disease conditions. The overall prevalence of CRC 
screening was 19%. The prevalence of CRC screening in adults with cancer history, hypertension, ulcer, high 
cholesterol, and arthritis were significantly higher than those without the chronic conditions (26% vs.18%, 
23% vs.16%, 25% vs.18%, 23% vs. 16%, and 23% vs. 17%, respectively). 
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Table 3 Univariate and multiple logistic regression analyses for the relationship between potential factors and CRC 
screening 
Variable Crude OR 95% CI 
 
P-value Adjusted OR      
 
95% CI P-value 
Gender       
  Male 1   1   
  Female 0.75 0.68-0.82 <0.0001 0.72 0.65-0.80 <0.0001 
Age group       
  18-44 years 1   1   
  45-64 years  2.98 2.42-3.68 <0.0001 2.60 2.11-3.21 <0.0001 
  65 + 3.76 3.03-4.66 <0.0001 2.67 2.13-3.33 <0.0001 
Race       
  White 1   1   
  AA 1.39 1.24-1.54 <0.0001 1.61 1.44-1.81 <0.0001 
  Asian 0.99 0.78-1.26 0.760 1.10 0.86-1.40 0.450 
  Other 0.81 0.68-0.96 0.0032 1.04 0.87-1.24 0.663 
Marital status       
  Married 1   1   
 Widowed/Divorced/Separate 0.90 0.82-0.99 0.0304 0.87 0.79-0.96 0.0072 
  Never 0.66 0.57-0.76 <0.0001 0.73 0.63-0.85 <0.0001 
Education       
  ≤HS 1   1   
  >HS 1.35 1.22-1.49 <0.0001 1.30 1.18-1.44 <0.0001 
Insurance       
  No 1   1   
  Yes 4.59 3.42-6.16 <0.0001 3.60 2.73-4.76 <0.0001 
Cancer       
  No 1   1   
  Yes 1.70 1.51-1.91 <0.0001 1.42 1.26-1.60 <0.0001 
Hypertension       
  No 1   1   
  Yes 1.58 1.45-1.72 <0.0001 1.18 1.08-1.30 0.0003 
Ulcer       
  No 1   1   
  Yes 1.50 1.31-1.73 <0.0001 1.28 1.10-1.48 0.0013 
High cholesterol       
  No 1   1   
  Yes 1.60 1.46-1.76 <0.0001 1.25 1.14-1.39 <0.0001 
Arthritis       
  No 1   1   
  Yes 1.55 1.41-1.70 <0.0001 1.24 1.12-1.37 <0.0001 
Abbreviations: AA=African American; HS=High school; OR=Odds ratio; CI=Confidence interval  
*Data Source: CDC/NCHS, National Health Interview Survey, 2012 
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The relationship between all potential risk factors and CRC screening  
Table 3 shows the results of both univariate and multiple regression analyses of the potential factors with 
CRC screening. All factors were associated with CRC in the univariate analysis (p<0.05). After adjusting for 
potential confounding factors, cancer history (OR=1.42, 95%CI=1.26-1.60), hypertension (OR=1.18, 
95%CI=1.08-1.30), ulcer (OR=1.28, 95%CI=1.10-1.48), high cholesterol (OR=1.25, 95%CI=1.14-1.39), and 
arthritis (OR=1.24, 95%CI=1.12-1.37) were all positively associated with CRC screening (p<0.05). Females 
were less likely to screen for CRC than males (OR=0.72; 95% CI=0.65-0.80). Compared to young adults 
(18-44 years), screening was significantly higher in middle-aged and elder adults (OR=2.60, 
95%CI=2.11-3.21 and OR=2.67, 95%CI=2.13-3.33, respectively). AAs were more likely to screen for CRC 
than white counterparts (OR=1.61, 95% CI=1.44-1.81). Compared to the married, screening uptake was less 
likely in the divorced/widowed/separated (OR=0.87, 95% CI=0.79-0.96) and in the never married (OR=0.73, 
95%CI=0.63-0.85). Education was significantly associated with CRC screening. Education level higher than 
senior high school is associated with 30% increase in the odds of CRC screening. The odds of CRC screening 
within the last 12 months in those who had insurance were 3.6 times that of those who did not have insurance 
(95% CI=2.73-4.76).  
Discussion 
In this study, we found that the prevalence of CRC screening in adults with cancer history, hypertension, ulcer, high 
cholesterol, and arthritis was significantly higher than those without those chronic conditions. After adjusting for 
potential confounding factors, cancer history, hypertension, ulcer, high cholesterol, and arthritis were all positively 
associated with CRC screening (p<0.05).  
As has been reported earlier, CRC screening rate is lower in women than men. Adjusting for all potential 
variables, CRC screening was still significantly higher in men than women. Some researchers have attributed 
the low uptake of CRC screening in women to the perception that CRC is men’s disease [17]. Others have 
proposed there is a greater attention to other cancers such as breast cancer and such attention has 
overshadowed the importance of CRC [22,23]. However, since presence of other chronic diseases has been 
found to increase uptake of CRC screening, the diverted attention hypothesis does not fully explain the 
gender difference in CRC screening. Again, since physician visit has been found to increase CRC screening 
[17,18], awareness of the conditions seems to be very important in the decision to screen.  
  We also found screening uptake to increase with age. More than 90% of all those who reported having been 
screened for CRC were over 44 years old. Screening uptake was highest in those above 64 years. The age 
difference is explained by the fact that CRC risk increases with age and screening is recommended for those 
who 50 years [26] and above in the US. 
  In terms of race, CRC screening uptake was significantly higher in AA compared to Whites while all other 
races were not significantly different from Whites. This finding contrasts earlier observations [15,16]. The 
higher uptake rate in AAs may be due to the fact that both incidence of and mortality from CRC are highest in 
AAs [27-31] than all other ethnic groups in the US. 
  Our results indicate that being married or living with a partner increases the chance of being screened for 
CRC. Those who are divorced, separated or widowed were also better off in uptake of CRC screening than 
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the never-married group. It has been known that being married is associated with CRC screening uptake [16].  
An earlier study attributed the health difference to financial protection enjoyed by unemployed married 
women [32]. However, Schoenborn (2004) observed that married adults were healthier than other adults 
regardless of population demographics or health indicator [33]. The difference in screening uptake, aside from 
other factors, may be due to support couples enjoy from their partners. However, a longitudinal study may be 
able to better explain this difference. 
  Level of education was also found to determine the likelihood of CRC screening uptake in our sample. 
Those who have received education higher than senior high school are more likely to receive screening for 
CRC. Education is well known to be a significant determinant of health. In terms of screening, education level 
of an individual may influence the level of understanding of CRC and the benefits of screening. Such insight 
is more likely to drive a person to accept and undergo screening [34]. 
  Insurance significantly increases the chances of being screened for CRC in our sample. Odds of been 
screened for CRC in the past 12 months in those insured were 3.6 times that of those who did not have any 
insurance. It has been shown that most insurance policies currently cover CRC screening [26]. Such coverage 
offers a relief of further financial burden from a CRC screening, and therefore lead to increased uptake of 
CRC screening by those insured. On the other hand, the uninsured may be constrained financially to screen 
for CRC. Again, differences in insurance status may reflect differences in economic level in our sample. 
Effect of insurance status on CRC screening may also be explained by health consciousness. With the same 
socio-economic levels, people who are more health conscious are more likely to buy health plans than those 
who are less health conscious. The difference in attitude toward health is more likely to result in significant 
differences in screening uptake. Another possible explanation for the effect of insurance status is risk 
perception. People who perceive themselves as being at increased risk for health problems are more likely to 
buy health plans and offer themselves for screening than those who perceive themselves as not being at risk 
for health problems. 
All of the chronic conditions included in the analysis were significantly associated with CRC screening 
uptake in both the univariate and multiple logistic regression analyses. Among the chronic conditions, cancer 
history showed the strongest association with CRC screening uptake. People diagnosed with cancer may 
consider themselves at risk of other cancers and therefore will take advantage of existing screening programs. 
Being treated for a cancer will likely expose an individual to the awareness of CRC screening and the benefit 
associated with it. It has been shown that family CRC history is a predictor for CRC screening [35]. History 
of having an ulcer was second to cancer in terms of strength of association with CRC screening. Investigation, 
treatment and education to ulcer patients are more likely to lead acceptance and uptake of CRC screening. 
Of greater interest is the effect of elevated cholesterol level on CRC screening uptake. It showed the third 
strongest strength of association with screening uptake. Since elevated cholesterol level is asymptomatic and 
more unlikely to lead people to seek medical attention, its association with CRC screening is more likely 
mediated by health consciousness. Furthermore, it has been reported that individuals who have high 
cholesterol do seem to have an increased risk of CRC [36].  
High blood pressure and arthritis also showed an association with CRC screening uptake. Like the other 
chronic conditions, hypertension and arthritis are more likely to bring patients into contacts with physicians 
and other health professionals more often. Such contacts may lead to awareness of available health services 
including CRC screening and increase in the uptake of screening. People coming into contact more often with 
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physicians are more likely to receive information on CRC screening, resulting in an increase in uptake [21,24]. 
Few studies have focused on the relationship between arthritis and hypertension and CRC screening. One 
recent study reported that individuals with rheumatoid arthritis (RA) did not appear to be at risk for receiving 
fewer cancer screening tests than non-RA patients; while there was no significant difference in having at least 
one Pap smear, mammogram or colonoscopy between patients with RA and hypertension [37]. 
Strengths and limitations 
Our study used a nationally representative sample and therefore the results can be generalized. The large 
sample size also gives us a statistical power in our estimates. However, since the study is a cross-sectional, 
causal association cannot be established. Further, our analysis is based on self-report and therefore prone to 
recall bias. However, colon cancer test is relatively invasive and it is unlikely that an individual will not recall 
this diagnosis. 
Conclusion 
We have found significant association between chronic conditions and CRC screening uptake. In contrast to 
earlier findings, we have found higher uptake of CRC screen in AA than Whites. Further studies should 
examine whether this association is mediated by physician visits. It is important to develop effective strategies 
to manage these chronic conditions; the role of physicians in the CRC screening should be stressed. 
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